Identification of Antibacterial Metabolites from Endophytic Fungus Isolated from Leaves (Fabaceae), Utilizing Metabolomic and Molecular Docking Techniques
Authors
Affiliations
The rapid spread of bacterial infection caused by has become a problem to public health despite the presence of past trials devoted to controlling the infection. Thus, the current study aimed to explore the chemical composition of the extract of endophytic fungus , isolated from leaves, and investigate the antimicrobial activity of isolated metabolites and their probable mode of actions. The chemical investigation of the fungal extract via UPLC/MS/MS led to the identification of at least forty-two metabolites, as well as the isolation and complete characterization of eight reported metabolites. The antibacterial activities of isolated metabolites were assessed against using agar disc diffusion and microplate dilution methods. Compounds ergosterol, helvolic acid and monomethyl sulochrin-4-sulphate showed minimal inhibitory concentration (MIC) values of 15.63, 1.95 and 3.90 µg/mL, respectively, compared to ciprofloxacin. We also report the inhibitory activity of the fungal extract on DNA gyrase and topoisomerase IV, which led us to perform molecular docking using the three most active compounds isolated from the extract against both enzymes. These active compounds had the required structural features for DNA gyrase and topoisomerase IV inhibition, evidenced via molecular docking.
Wang H, Yuan X, Huang X, Zhang P, Gu G Plants (Basel). 2025; 14(2).
PMID: 39861526 PMC: 11768264. DOI: 10.3390/plants14020173.
Abdalla S, Moghazy R, Hamed A, Abdel-Monem M, El-Khateeb M, Hassan M Microb Cell Fact. 2024; 23(1):288.
PMID: 39438859 PMC: 11495080. DOI: 10.1186/s12934-024-02537-4.
Ibrahim R, Abdel-Baki P, Mohamed O, Al-Karmalawy A, Tripathi A, El-Shiekh R Sci Rep. 2024; 14(1):19637.
PMID: 39179586 PMC: 11344142. DOI: 10.1038/s41598-024-68743-7.
Abdelrahman S, El Hawary S, Mohsen E, El Raey M, Selim H, Hamdan A Front Microbiol. 2024; 15:1366614.
PMID: 38803373 PMC: 11128569. DOI: 10.3389/fmicb.2024.1366614.
Mounir R, Alshareef W, El Gebaly E, El-Haddad A, Ahmed A, Mohamed O Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895850 PMC: 10609719. DOI: 10.3390/ph16101379.